HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

5.560

-0.710-11.32%

Volume:8.44M

Turnover:49.06M

Market Cap:2.11B

PE:-5.96

High:6.270

Open:6.270

Low:5.545

Close:6.270

52wk High:22.560

52wk Low:5.350

Shares:380.07M

HK Float Shares:375.46M

Volume Ratio:1.04

T/O Rate:2.25%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.934

ROE:-70.66%

ROA:-28.19%

PB:6.94

PE(LYR):-5.96

PS:16923.50

Loading ...

Overview Company News Filings

Strategic Collaboration Sees Qilu Invest RMB 400 Million in TYK MEDICINES-B for TY-9591 Development and Commercialization

TYK Medicines Prices Private Placement of 63,222,744 H Shares at HK$ 7.3 Each

Tyk Medicines - to Receive Aggregate Upfront Payment of Rmb700 Mln Plus Potential Milestone Payments

THOMSON REUTERS

Tyk Medicines - Co Enters License and Collaboration Agreement with Qilu for Ty-9591 in China

THOMSON REUTERS

Hong Kong Shares Surge: TYK MEDICINES-B Soars Over 15% in Afternoon Trading on Key Drug Trial Results

TYK MEDICINES-B Shares Surge Over 15% on Upcoming Commercialization of TY-9591 and Positive Clinical Data for Edotinib

TYK MEDICINES-B Shares Surge Over 6% on Positive Clinical Data for Brain Metastasis Drug, Anticipated Q3 Launch

TYK Medicines Convenes 15 July 2026 EGM to Secure Share-Issuance Mandate

Bulletin Express

TYK Medicines Seeks Shareholders’ Approval for 20% General Share Issuance Mandate

Bulletin Express

TYK Medicines Announces Extraordinary General Meeting

TYK Medicines Sets 10–15 July 2026 Book Closure to Determine EGM Voting Entitlements

Bulletin Express

TYK Medicines shareholders pass Articles of Association amendments at AGM

TYK Medicines Keeps Share Capital Steady at 380.07 Million H Shares in May; Public Float Meets 25% Rule

Bulletin Express

Major Breakthrough at ASCO 2026: TYK MEDICINES-B's Edotinib Achieves 95.5% Intracranial Objective Response Rate, Leading the Frontline Treatment for EGFR Lung Cancer Brain Metastases

TYK Medicines reports superior interim Phase II data for asandeutertinib versus osimertinib in first-line EGFR-mutant NSCLC with brain metastases

Bulletin Express

Key Phase II ESAONA Study Results for TYK MEDICINES-B's (02410) TY-9591 in First-Line NSCLC Brain Metastases Presented as Late-Breaking Abstract at 2026 ASCO

TYK Medicines says Phase II study shows asandeutertinib beats osimertinib on intracranial response in EGFR-mutant NSCLC with brain metastases

TYK Medicines Releases 2025 AGM Agenda Covering Profit Distribution, Share Mandates and Board Re-election

Bulletin Express

TYK Medicines to Seek 20% Share Issue Mandate, RMB300 Million Bank Lines and No-Dividend Plan at 23 June AGM

Bulletin Express

Insiders Could Have Profited By Holding onto TYK Medicines Shares Despite 12% Drop

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/02410/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":5.56,"timestamp":1788163728007,"preClose":6.27,"halted":0,"volume":8444000,"delay":0,"changeRate":-0.11323763955342903,"floatShares":375457818,"shares":380065818,"eps":-0.9335758183870564,"marketStatus":"Not Yet Opened","change":-0.71,"latestTime":"08-31 16:08:48","open":6.27,"high":6.27,"low":5.545,"amount":49061452,"amplitude":0.11563,"askPrice":5.56,"askSize":6000,"bidPrice":5.555,"bidSize":45000,"shortable":3,"etf":0,"ttmEps":-0.6552710320770099,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":6.27,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":1.0447391863854536,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-28.19%","roe":"-70.66%","lyrEps":-0.933576,"volumeRatio":1.0447391863854536,"shares":380065818,"dividePrice":0,"high":6.27,"amplitude":0.11563,"preClose":6.27,"low":5.545,"week52Low":5.35,"pbRate":"6.94","psRate":"16923.50","week52High":22.56,"institutionHeld":0,"latestPrice":5.56,"committee":0.764706,"eps":-0.9335758183870564,"divideRate":0,"volume":8444000,"delay":0,"ttmEps":-0.6552710320770099,"open":6.27,"prevYearClose":13.11,"prevWeekClose":6.27,"prevMonthClose":5.56,"prevQuarterClose":5.73,"fiveDayClose":6.33,"twentyDayClose":6.795,"sixtyDayClose":7.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-08-31","current":-8.485039,"percent":0.905622,"low":-45.171338,"twenty":-23.879514,"median":-17.04285,"eighty":-12.161459,"high":-6.195227,"avg":-18.0065,"sd":7.188158,"marketCap":2138786428},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-13","current":-15.334427,"twenty":-24.923448,"median":-18.860882,"eighty":-16.099082,"marketCap":4864842470},{"date":"2026-02-20","current":-15.572498,"twenty":-24.905533,"median":-18.847277,"eighty":-16.071561,"marketCap":4933254317},{"date":"2026-02-27","current":-14.952615,"twenty":-24.827654,"median":-18.801141,"eighty":-15.988536,"marketCap":4788829306},{"date":"2026-03-06","current":-13.279596,"twenty":-24.77147,"median":-18.709822,"eighty":-15.892604,"marketCap":4218730579},{"date":"2026-03-13","current":-12.861452,"twenty":-24.760877,"median":-18.616931,"eighty":-15.828013,"marketCap":4104710834},{"date":"2026-03-20","current":-12.157235,"twenty":-24.758022,"median":-18.440891,"eighty":-15.765099,"marketCap":3865269369},{"date":"2026-03-27","current":-12.164275,"twenty":-24.758022,"median":-18.409208,"eighty":-15.692499,"marketCap":3857668052},{"date":"2026-04-02","current":-12.25818,"twenty":-24.73228,"median":-18.399621,"eighty":-15.606124,"marketCap":4180723998},{"date":"2026-04-10","current":-12.412577,"twenty":-24.72344,"median":-18.391406,"eighty":-15.554796,"marketCap":4266032641},{"date":"2026-04-17","current":-12.351427,"twenty":-24.717087,"median":-18.309793,"eighty":-15.461655,"marketCap":4246798950},{"date":"2026-04-24","current":-11.422185,"twenty":-24.709149,"median":-18.216326,"eighty":-15.337994,"marketCap":3927519681},{"date":"2026-04-30","current":-11.117278,"twenty":-24.702871,"median":-18.174743,"eighty":-15.304685,"marketCap":3823657750},{"date":"2026-05-08","current":-10.777891,"twenty":-24.684547,"median":-18.056929,"eighty":-15.189837,"marketCap":3719795820},{"date":"2026-05-15","current":-9.293361,"twenty":-24.617578,"median":-17.965815,"eighty":-15.119492,"marketCap":3215873118},{"date":"2026-05-22","current":-8.991533,"twenty":-24.605712,"median":-17.939574,"eighty":-15.043492,"marketCap":3104317711},{"date":"2026-05-29","current":-10.14843,"twenty":-24.599189,"median":-17.918048,"eighty":-14.961326,"marketCap":3515918696},{"date":"2026-06-05","current":-8.237808,"twenty":-24.571342,"median":-17.89208,"eighty":-14.895383,"marketCap":2858126467},{"date":"2026-06-12","current":-7.644268,"twenty":-24.535606,"median":-17.732128,"eighty":-14.684931,"marketCap":2650402606},{"date":"2026-06-18","current":-6.884404,"twenty":-24.459385,"median":-17.688347,"eighty":-14.384241,"marketCap":2392671147},{"date":"2026-06-26","current":-6.195227,"twenty":-24.397853,"median":-17.672452,"eighty":-13.470121,"marketCap":2142633166},{"date":"2026-07-03","current":-7.179757,"twenty":-24.364887,"median":-17.499062,"eighty":-13.369605,"marketCap":2484992864},{"date":"2026-07-10","current":-8.078806,"twenty":-24.314468,"median":-17.476751,"eighty":-13.262753,"marketCap":2792731918},{"date":"2026-07-17","current":-8.127776,"twenty":-24.232724,"median":-17.419476,"eighty":-13.079412,"marketCap":2819659085},{"date":"2026-07-24","current":-7.604914,"twenty":-24.150839,"median":-17.377721,"eighty":-12.93356,"marketCap":2638862391},{"date":"2026-07-31","current":-7.53517,"twenty":-24.119743,"median":-17.333807,"eighty":-12.87079,"marketCap":2619628700},{"date":"2026-08-07","current":-7.625479,"twenty":-24.07756,"median":-17.320685,"eighty":-12.528428,"marketCap":2656172713},{"date":"2026-08-14","current":-7.417307,"twenty":-24.00283,"median":-17.276309,"eighty":-12.375887,"marketCap":2586931426},{"date":"2026-08-21","current":-10.34776,"twenty":-23.939778,"median":-17.197085,"eighty":-12.303816,"marketCap":2563850996},{"date":"2026-08-28","current":-9.732294,"twenty":-23.880566,"median":-17.053511,"eighty":-12.176647,"marketCap":2411904838},{"date":"2026-08-31","current":-8.633905,"twenty":-23.879514,"median":-17.04285,"eighty":-12.161459,"marketCap":2138786428}],"updateTime":1788220555807},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1118550534","title":"Strategic Collaboration Sees Qilu Invest RMB 400 Million in TYK MEDICINES-B for TY-9591 Development and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=1118550534","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118550534?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:37","pubTimestamp":1784633835,"startTime":"0","endTime":"0","summary":"The company TYK MEDICINES-B (02410) has announced a strategic partnership with Qilu Pharmaceutical. On July 21, 2026, following the trading day, the company entered into a license and cooperation...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TY","BK1515","BK1161","09939","159938","BK1574","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653325274","title":"TYK Medicines Prices Private Placement of 63,222,744 H Shares at HK$ 7.3 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2653325274","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653325274?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:22","pubTimestamp":1784632920,"startTime":"0","endTime":"0","summary":"TYK Medicines prices private placement of 63,222,744 H shares at HK$ 7.3 eachTYK Medicines set a private placement of 63,222,744 new H Shares to Qilu’s wholly owned unit Anchor International.Deal pric","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL7S4P1w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927434","title":"Tyk Medicines - to Receive Aggregate Upfront Payment of Rmb700 Mln Plus Potential Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927434?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:21","pubTimestamp":1784632913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0PW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653274393","title":"Tyk Medicines - Co Enters License and Collaboration Agreement with Qilu for Ty-9591 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2653274393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653274393?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:21","pubTimestamp":1784632913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138336031","title":"Hong Kong Shares Surge: TYK MEDICINES-B Soars Over 15% in Afternoon Trading on Key Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1138336031","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138336031?lang=en_us&edition=fundamental","pubTime":"2026-07-21 13:46","pubTimestamp":1784612808,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (02410) experienced a significant surge in afternoon trading, rising more than 15%. At the time of writing, the stock was up 12.37% to HK$8.54, with a turnover of HK$53.76...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1515","BK1574","09939","02410","KCAI","BK1161","IPOS","159938","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176636503","title":"TYK MEDICINES-B Shares Surge Over 15% on Upcoming Commercialization of TY-9591 and Positive Clinical Data for Edotinib","url":"https://stock-news.laohu8.com/highlight/detail?id=1176636503","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176636503?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:44","pubTimestamp":1783997070,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (ASX: 02410) surged more than 15% during the trading session. At the time of writing, the stock was up 12.68% to HK$7.82, with a turnover of HK$49.356 million. Positive...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","VXUS","BK4588","KCAI","BK1574","BK4585","BK1161","09939","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183710760","title":"TYK MEDICINES-B Shares Surge Over 6% on Positive Clinical Data for Brain Metastasis Drug, Anticipated Q3 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1183710760","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183710760?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:35","pubTimestamp":1783481755,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (ASX: 02410) have risen more than 6%. At the time of writing, the stock is up 5.63% to HK$6.76, with a turnover of HK$11.09 million. The positive movement follows the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1515","09939","BK4585","159938","IPOS","KCAI","VXUS","BK1574","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127030077","title":"TYK Medicines Convenes 15 July 2026 EGM to Secure Share-Issuance Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1127030077","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127030077?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:25","pubTimestamp":1782735921,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (浙江同源康醫藥股份有限公司) has issued a notice and proxy form for its first extraordinary general meeting (EGM) of 2026, scheduled for 2:00 p.m. on Wednesday, 15 July 2026. The session will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109519601","title":"TYK Medicines Seeks Shareholders’ Approval for 20% General Share Issuance Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1109519601","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109519601?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:05","pubTimestamp":1782734754,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. will convene its first extraordinary general meeting of 2026 on 15 July 2026 at 2:00 p.m. in Shanghai. The sole agenda item is a special resolution authorizing the Board to issue...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379548","title":"TYK Medicines Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379548","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379548?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:58","pubTimestamp":1782734304,"startTime":"0","endTime":"0","summary":"TYK Medicines announces extraordinary general meetingTYK Medicines will hold an extraordinary general meeting in Shanghai on July 15, 2026.Shareholders will vote on a general mandate authorizing the b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLbF8dZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152333401","title":"TYK Medicines Sets 10–15 July 2026 Book Closure to Determine EGM Voting Entitlements","url":"https://stock-news.laohu8.com/highlight/detail?id=1152333401","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152333401?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:44","pubTimestamp":1782290682,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. will close its register of members from Friday, 10 July 2026 to Wednesday, 15 July 2026, inclusive. The suspension of share transfers is intended to establish shareholder...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645838829","title":"TYK Medicines shareholders pass Articles of Association amendments at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2645838829","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645838829?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:44","pubTimestamp":1782211490,"startTime":"0","endTime":"0","summary":"Shareholders passed amendments to TYK Medicines’ articles of association at the 2025 AGM on June 23, 2026.The special resolution drew 8,036,001 votes for , 19,500 against , 10,500 abstentions .The meeting also rejected a separate share-issuance mandate, with 41.56% in favor and 58.04% abstaining.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TYK Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL4kNSF6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104429351","title":"TYK Medicines Keeps Share Capital Steady at 380.07 Million H Shares in May; Public Float Meets 25% Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=1104429351","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104429351?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:44","pubTimestamp":1780397051,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (PRC-incorporated, listed in Hong Kong) reported no change in its share structure for the month ended 31 May 2026, according to the Monthly Return filed on 2 June 2026. Registered...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134286006","title":"Major Breakthrough at ASCO 2026: TYK MEDICINES-B's Edotinib Achieves 95.5% Intracranial Objective Response Rate, Leading the Frontline Treatment for EGFR Lung Cancer Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=1134286006","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134286006?lang=en_us&edition=fundamental","pubTime":"2026-06-01 10:13","pubTimestamp":1780280012,"startTime":"0","endTime":"0","summary":"A key clinical breakthrough was announced at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. TYK MEDICINES-B (02410), a Hong Kong-listed innovative pharmaceutical company,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","02410","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192011753","title":"TYK Medicines reports superior interim Phase II data for asandeutertinib versus osimertinib in first-line EGFR-mutant NSCLC with brain metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=1192011753","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192011753?lang=en_us&edition=fundamental","pubTime":"2026-05-31 18:24","pubTimestamp":1780223069,"startTime":"0","endTime":"0","summary":"TYK Medicines (02410.HK) released interim results from the pivotal Phase II ESAONA study comparing asandeutertinib (TY-9591) with osimertinib as first-line therapy for epidermal growth factor...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151955380","title":"Key Phase II ESAONA Study Results for TYK MEDICINES-B's (02410) TY-9591 in First-Line NSCLC Brain Metastases Presented as Late-Breaking Abstract at 2026 ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=1151955380","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151955380?lang=en_us&edition=fundamental","pubTime":"2026-05-31 18:20","pubTimestamp":1780222827,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) announced that the interim analysis results from the pivotal Phase II ESAONA study for its self-developed drug, TY-9591 (mesylate edotinib tablets), versus osimertinib in the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1515","BK1161","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639600295","title":"TYK Medicines says Phase II study shows asandeutertinib beats osimertinib on intracranial response in EGFR-mutant NSCLC with brain metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2639600295","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639600295?lang=en_us&edition=fundamental","pubTime":"2026-05-31 18:11","pubTimestamp":1780222303,"startTime":"0","endTime":"0","summary":"TYK Medicines says Phase II study shows asandeutertinib beats osimertinib on intracranial response in EGFR-mutant NSCLC with brain metastases. TYK Medicines highlighted interim results from its pivotal Phase II ESAONA trial of asandeutertinib in EGFR-mutant NSCLC with brain metastases.Results were already presented as a late-breaking oral abstract at the 2026 ASCO Annual Meeting.The study showed stronger control of brain metastases versus AstraZeneca’s osimertinib, with a manageable safety profile.Systemic disease control also favored asandeutertinib, supporting a potential new first-line positioning in this patient group.An NDA has been accepted in China and placed into a priority review pathway, with longer-term follow-up still ongoing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nNDL3gRqnT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149674578","title":"TYK Medicines Releases 2025 AGM Agenda Covering Profit Distribution, Share Mandates and Board Re-election","url":"https://stock-news.laohu8.com/highlight/detail?id=1149674578","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149674578?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:45","pubTimestamp":1779439549,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. has issued the proxy form for its 2025 Annual General Meeting scheduled for 2:00 p.m. on 23 June 2026 at 8/F, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167825735","title":"TYK Medicines to Seek 20% Share Issue Mandate, RMB300 Million Bank Lines and No-Dividend Plan at 23 June AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1167825735","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167825735?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:44","pubTimestamp":1779439446,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. (TYK Medicines) released its 2025 AGM circular dated 22 May 2026, detailing resolutions to be tabled on 23 June 2026 in Shanghai. Financial Reporting and Dividend   • The audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635776438","title":"Insiders Could Have Profited By Holding onto TYK Medicines Shares Despite 12% Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2635776438","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635776438?lang=en_us&edition=fundamental","pubTime":"2026-05-14 11:15","pubTimestamp":1778728529,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc's (HKG:2410) value has fallen 12% in the last week, but insiders who sold CN¥4.2m worth of stock...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/insiders-could-have-profited-by-holding-onto-tyk-medicines-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/insiders-could-have-profited-by-holding-onto-tyk-medicines-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02410","MDCO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}